Sigma Planning Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$694K Sell
10,053
-1,340
-12% -$92.5K 0.02% 647
2025
Q1
$793K Sell
11,393
-362
-3% -$25.2K 0.03% 563
2024
Q4
$1.01M Sell
11,755
-3,842
-25% -$330K 0.03% 482
2024
Q3
$1.86M Sell
15,597
-967
-6% -$115K 0.06% 310
2024
Q2
$2.36M Sell
16,564
-372
-2% -$53.1K 0.07% 248
2024
Q1
$2.17M Buy
16,936
+7,299
+76% +$937K 0.07% 286
2023
Q4
$997K Sell
9,637
-1,923
-17% -$199K 0.08% 271
2023
Q3
$1.05M Buy
11,560
+5,628
+95% +$512K 0.04% 444
2023
Q2
$480K Buy
5,932
+1,758
+42% +$142K 0.02% 747
2023
Q1
$332K Sell
4,174
-618
-13% -$49.2K 0.01% 966
2022
Q4
$324K Sell
4,792
-584
-11% -$39.5K 0.01% 935
2022
Q3
$268K Sell
5,376
-376
-7% -$18.7K 0.01% 980
2022
Q2
$321K Buy
5,752
+864
+18% +$48.2K 0.01% 955
2022
Q1
$271K Sell
4,888
-48
-1% -$2.66K 0.01% 1096
2021
Q4
$276K Buy
4,936
+200
+4% +$11.2K 0.01% 1114
2021
Q3
$227K Buy
+4,736
New +$227K 0.01% 1185
2016
Q1
Sell
-7,156
Closed -$208K 743
2015
Q4
$208K Sell
7,156
-1,056
-13% -$30.7K 0.03% 587
2015
Q3
$223K Buy
+8,212
New +$223K 0.04% 526
2015
Q2
Sell
-16,954
Closed -$453K 751
2015
Q1
$453K Buy
16,954
+100
+0.6% +$2.67K 0.06% 371
2014
Q4
$357K Buy
+16,854
New +$357K 0.05% 440